Learn more about how medical devices are authorized and the challenges foreign manufacturers face when seeking to register products in Japan.
Find out how MO#169 and ISO 13485 vary and the audit processes for national, international and contract manufacturers entering Japan’s medical device market.
Discover how transfer affects autoinjector users transitioning from syringes, pen-injectors, or emergency devices and learn strategies to address these challenges in product design for safer medication delivery.
During this interactive session, our senior HFE experts answer pre-submitted and live questions about conducting and documenting use-related risk analyses of medical devices.
Emergo by UL human factors specialists discuss the most frequent topics among HFE-related feedback provided by the FDA.
As noted in a previous Regulatory Update, a draft Post-Market Surveillance statutory instrument (PMS SI) was laid in Parliament (Oct. 21,) to introduce new PMS requirements.
You might have heard some rumors already: Several European parliamentarians sent a joint motion for resolution to the European Commission (EC). On October 21st, 2024, a European Parliament resolution “on the urgent need to revise the Medical Devices Regulation” (2024/2849(RSP)) was submitted to the EC.
The draft Post-Market Surveillance statutory instrument (PMS SI) was laid (Oct. 22,) in parliament.
In this on-demand webinar, our Emergo by UL subject matter expert will share insights on Regulation (EU) 2024/1860 and IVDR transition periods in Europe.
The International Medical Device Regulators Forum (IMDRF) published a new technical document from the Adverse Event Terminology Working Group (AET WG) this month Common Data Set for Adverse Event Data Exchange Between IMDRF Regulators, or in brief, N85.